48804
ASPEN TREASURY IRELAND LIMITED
Sep 4, 2024
South Africa
Africa
Jul 2, 2024
B - Limited
Active
Sep 28, 2024
Regional Industry - MAS Africa
other
Approved : Jul 2, 2024
Signed : Aug 6, 2024
Invested : Sep 25, 2024
other
The proposed investment is an up to EUR500 million financing package comprising (i) an unsecured, straight senior loan (“A” loan) of up to EUR150 million from IFC and; (ii) mobilization of parallel loans of up to EUR350 million to Aspen Treasury Ireland Limited (ATIL), a wholly owned subsidiary of Aspen Pharmacare Holdings Limited (Aspen or the Company). The financing will support: (i) Aspen’s corporate financing program to assist the Company in expanding its capacity to deliver medicines, diabetes insulin and paediatric vaccines in Africa; the Company’s investment in ongoing product development and acquisition of product portfolios; (iii) the Company’s investments in emerging markets manufacturing capabilities; and (iv) to refinance existing debt and strengthen the Company’s balance sheet.
(i) IFC will provide services related to supporting Aspen in developing its decarbonization roadmap for its pharmaceutical facility in Gqeberha; and (ii) Aspen, along with other leading companies and industry leaders, will participate in IFC’s inaugural South Africa gender specific program focused on creating respectful workplaces, free from violence and harassment.
For Inquiries About the Project, Contact
For Inquiries and Comments About IFC, Contact
Local Access of Project Documentation
IFC Communications, 2121 Pennsylvania Avenue, NW, Washington DC 20433
Telephone: 202-473-3800
Fax: 202-974-4384